Sign Up
Stories
Pulse Biosciences Expands Cardiac Ablation Technology
Share
FDA Breakthrough Device Designation for ...
Global Electrophysiology Market Growth
Growing Markets in Healthcare Technology
AI-Powered Raspberry Pi Stethoscope Inno...
Advanced Technology Saves Patient's Life
Attune Medical's Growth in Esophageal Te...
Overview
API
Pulse Biosciences files 510(k) submission for its CellFX nsPFA Cardiac Clamp, a non-thermal device for cardiac ablation, aiming to expand into the cardiac market.
Ask a question
How might the non-thermal technology of Pulse Biosciences' CellFX nsPFA Cardiac Clamp impact the traditional thermal ablation technologies in the cardiac market?
In what ways could the non-thermal technology of the CellFX nsPFA Cardiac Clamp influence the future of cardiac ablation procedures?
What are the potential implications of expanding into the cardiac market for Pulse Biosciences and the healthcare industry as a whole?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage